Retrospective analysis of the impact of kidney function on the outcomes of first autografts for de novo myeloma patients in the era of novel agents
Lajos Flóró(King's College Hospital), Stephen Schey(University College Hospital), Stephanie M. Ware(Indiana University School of Medicine), Douglas Gunning(King's College Hospital), Ιωάννα Λαζανά(King's College Hospital), Matthew Streetly(King's College - North Carolina), Sapna Shah(King's College London), Shameem Mahmood(King's College - North Carolina), M. Kazmi(St Thomas' Hospital), Reuben Benjamin(King's College London)
Cited by 1
Related Papers
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
|Blood|2000|502
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
|Blood|2023|330
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
|Journal of Clinical Oncology|2004|315